MedPath

Treatment of Garbhashaya arbuda with Virechana,Lekhana Basti and oral therapy

Not Applicable
Registration Number
CTRI/2019/03/018099
Lead Sponsor
INSTITUTE FOR POST GRADUATION TEACHING AND RESEARCH IN AYURVEDA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Both married and unmarried patient Age group between 20year TO 50years.

2.Patients having fibroid size 5 cm and < 5cm as per USG report

3.Single or multiple fibroids

4.The patient either asymptomatic or having clinical signs and symptoms of uterine fibroid.

5.Women with Hb > 7 gm%

6.Patient are suitable (Yogya) for Basti and Virechana

Exclusion Criteria

1.Patient <20 years and >50 years

2.Patient having fibroid size more than 5 cm as per USG report

3.Pregnant women with fibroid

4.Women with Hb < 7 gm%

5.Ovarian tumour, Tubo-ovarian mass and malignant tumours along with fibroid.

6.Patient with uncontrolled hypertension, tuberculosis, Diabetes Mellites and any other severe systemic disease.

7.Patients are not suitable (Yogya) for Basti and Virechana

8.Patients not willing to do Virechana and Basti

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To explore, correlate and review of uterine Fibroid with Grabhashaya Arbuda in Ayurvedic parlance. <br/ ><br>To develop a standard Ayurvedic treatment protocol for management of Grabhashaya Arbuda (Uterine fibroid) <br/ ><br>Timepoint: Virechana,lekhana basti 16 days 1 cycle,varunadi kwatha for 3 month
Secondary Outcome Measures
NameTimeMethod
To evaluate & establish the efficacy of treatment protocol i.e Virechana Karma, Lekhana Basti and Oral therapy in the management of uterine fibroid(Garbhashaya Arbuda).Timepoint: Virechana,lekhana basti 16 days 1 cycle,varunadi kwatha for 3 month
© Copyright 2025. All Rights Reserved by MedPath